Resmed (RSMDF) Cash from Investing Activities (2009 - 2026)

Resmed (RSMDF) has reported Cash from Investing Activities for 18 consecutive years, with -$383.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 186.92% year-over-year to -$383.7 million; the trailing twelve-month figure through Jun 2026 stood at -$545.2 million (down 172.54% YoY), and the FY2026 full-year result was -$545.2 million, down 172.54% from the prior year.
• Cash from Investing Activities retreated to -$383.7 million in Q2 2026 per RSMDF's latest filing, from -$58.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $2.1 million in Q3 2024 and bottomed at -$1.0 billion in Q4 2022.
• Historically, Cash from Investing Activities has averaged -$126.6 million across 5 years, with a median of -$50.2 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities surged 101.44% in 2024, then slumped 2550.05% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$1.0 billion in 2022, then soared by 95.99% to -$41.1 million in 2023, then advanced by 10.82% to -$36.7 million in 2024, then sank by 38.84% to -$50.9 million in 2025, then plunged by 653.11% to -$383.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$383.7 million, -$58.0 million, and -$50.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.